Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4.
about
Phenotypic mixing during coinfection of cells with two strains of human rotavirusIsolation of human monoclonal antibodies that neutralize human rotavirusBovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates.Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections.Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin.Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3.Rotavirus vaccines: an overview.Serum rotavirus neutralizing-antibody titers compared by plaque reduction and enzyme-linked immunosorbent assay-based neutralization assaysHuman viral gastroenteritis.Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro.Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus.Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigenAcrylamide concentration affects the relative position of VP7 gene of serotype G2 strains as determined by polyacrylamide gel electrophoresisRotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of lifeReactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine.Analysis by RNA-RNA hybridization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo.Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.Identification of serotype 9 human rotavirus by enzyme-linked immunosorbent assay with monoclonal antibodies.A longitudinal cohort study in calves evaluated for rotavirus infections from 1 to 12 months of age by sequential serological assaysGenetic relatedness among human rotavirus genes coding for VP7, a major neutralization protein, and its application to serotype identification.Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.Isolation and characterization of a novel reassortant between avian Ty-1 and simian RRV rotaviruses.Genetic determinants restricting the reassortment of heterologous NSP2 genes into the simian rotavirus SA11 genome.Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus.Isolation of an avianlike group A rotavirus from a calf with diarrhea.Molecular analysis of the VP7, VP4, VP6, NSP4, and NSP5/6 genes of a buffalo rotavirus strain: identification of the rare P[3] rhesus rotavirus-like VP4 gene allele.
P2860
Q27486879-1D22B368-5331-4FFB-A1A2-B2C7D3C7993AQ33199391-CC3C35F1-4E7B-453E-84C1-31A89E53D658Q33604189-0CBABECE-A073-432E-A49D-9C5BC6D5F8D9Q33782483-9DD8448D-5BA0-406B-A61F-F1FAE222E45CQ34335469-09027546-3D70-49DE-AF92-5669DE6F165AQ35123345-FBD5FBAB-7ACE-47AC-A440-30804964A886Q35371774-7E3B4C37-9848-4AAD-A984-88285F9A55E2Q36530963-FBC9AFD4-F67D-4BCE-B71B-F428EF560F21Q36634738-5A88B4EF-CD14-45AA-87BE-A8EA87890F5AQ36637434-A17A6C48-5E67-4BBF-B18B-74EB6FABBF80Q36637672-6D027157-760E-4616-A46C-5E6C0903A7CFQ36795096-3F7A72F9-9A78-4A58-B475-24647C4D5185Q36866633-DA8094FC-D482-42C5-A5E2-44699EFC859CQ36875550-602B86DF-F8D9-4EE1-B136-3D1A8C9D4CA6Q36952509-204FEA1D-A248-4C08-BA13-27392931D484Q37065953-469F5460-188C-47B7-9CCC-71F0333025D5Q37133579-2EA90679-022B-4D3B-A6A5-28381B276E5AQ37135981-F5F42112-48D4-477B-8534-336AA713734AQ37164301-6CD78107-E74A-45C0-8419-C699ED3E0FCCQ37169945-5156089C-36EE-4381-A7E7-B4FB8E445267Q37180510-2842AE8C-DFEE-4648-96E3-F16B6FA9DB66Q37186138-CFEE0EF9-0047-4FB9-A241-1C90533DA751Q37215560-ED466A17-CB8A-41F9-B349-6C88104FE055Q37228110-D1F3F891-6E89-4122-B044-FDCC63F55D47Q40060962-92E949AB-1FBB-4DDF-AE51-C486235692B9Q40071114-EBA8A3AB-6BC6-458E-940D-69B97A4A2126Q40109159-967D6899-3953-42C0-A27A-284EAD0593F4Q40184953-A7C8E78F-CFBA-4792-B8BE-972CA8527F55Q40404282-ED993B89-12DF-4F21-BBAA-B2351B0CFF5C
P2860
Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Single gene substitution rotav ...... of human rotavirus serotype 4.
@en
Single gene substitution rotav ...... e major neutralization protein
@nl
type
label
Single gene substitution rotav ...... of human rotavirus serotype 4.
@en
Single gene substitution rotav ...... e major neutralization protein
@nl
prefLabel
Single gene substitution rotav ...... of human rotavirus serotype 4.
@en
Single gene substitution rotav ...... e major neutralization protein
@nl
P2093
P2860
P1476
Single gene substitution rotav ...... of human rotavirus serotype 4.
@en
P2093
Chanock RM
Kapikian AZ
P2860
P304
P407
P577
1986-11-01T00:00:00Z